Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-20

Clinical Trial Update: Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN) [Phase 2]

View source ↗

Summary

Phase 2 trial update for capsaicin to prevent delayed chemotherapy-induced nausea and vomiting (CapCIN) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capsaicin (capsaicin)

Snippet

Sponsor: Christian Medical College, Vellore, India | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: COMPLETED